https://endpts.com/pfizer-ceo-points-to-ira-as-a-factor-that-made-seagen-an-attractive-target/
One of the reasons Pfizer sought to purchase Seagen, as part of a $43 billion deal announced this morning, is that the Seattle-based biotech will be able to withstand the coming headwinds of the Inflation Reduction Act and the Medicare price negotiations that…
Create an account
or login to join the discussion